Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging.
| Autor: | Tawakol, Ahmed1 atawakol@partners.org, Singh, Parmanand2, Rudd, James H.F.3, Soffer, Joseph4, Cai, Gengqian4, Vucic, Esad2, Brannan, Sarah P.4, Tarka, Elizabeth A.4, Shaddinger, Bonnie C.4, Sarov-Blat, Lea4, Matthews, Paul4,5, Subramanian, Sharath2, Farkouh, Michael6,7, Fayad, Zahi A.6,8 |
|---|---|
| Zdroj: | Journal of the American College of Cardiology (JACC). Jan2014, Vol. 63 Issue 1, p86-88. 3p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|